A comparison of the different electromyography-based neuromuscular monitor, the AF-201P and the TetraGraph, in rocuronium-induced neuromuscular block: A prospective comparative study
Not Applicable
- Conditions
- Patients undergoing general anesthesia
- Registration Number
- JPRN-UMIN000044624
- Lead Sponsor
- ihon University Itabashi Hospital Department of Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with American Society of Anesthesiologists physical status classification 4 or more, patients with a history of allergic reaction to NMBAs, patients with hepatic disease, patients with neuromuscular disease, and patients who were receiving medication known to interfere with neuromuscular function.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time from administration of rocuronium to first appearance of PTC response
- Secondary Outcome Measures
Name Time Method The supramaximal current, baseline compound action potential, time from administration of rocuronium to TOFC0 (onset time), time from administration of rocuronium to first reappearance of TOFC1 (time to TOFC1), time from administration of rocuronium to first reappearance of TOFC2 (time to TOFC2), and time from administration of sugammadex to TOF ratio 90% or higher